A new glycosylated derivative of rausuquinone with cytotoxic activity from Streptomyces sp. HU061-2
- 19 August 2025
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 78 (11) , 697-699
Abstract
A new glycosylated derivative of rausuquinone, rausuquinonoside (1), was isolated from the Tai Lake sediment-derived actinomycete, Streptomyces sp. HU061-2. The structure of 1 was determined by 1D, 2D NMR, MS spectral analysis and the comparison with data from the literature. Bioassay test showed that 1 exhibited potent cytotoxic activity against tumor cell lines HepG2, HCT116 and A549.Keywords
This publication has 8 references indexed in Scilit:
- Anulamycins A–F, Cinnamoyl-Containing Peptides from a Lake Sediment Derived StreptomycesJournal of Natural Products, 2023
- Two new 22-membered macrolides from Streptomyces sp. HU210The Journal of Antibiotics, 2022
- Sarubicinols A–C, Cytotoxic Benzoxazoles from a StreptomycesJournal of Natural Products, 2022
- Two new cyclopentenone metabolites from Streptomyces sp. HU119Journal of Asian Natural Products Research, 2022
- Rausuquinone, a non-glycosylated pluramycin-class antibiotic from RhodococcusThe Journal of Antibiotics, 2021
- Distributions of four taste and odor compounds in the sediment and overlying water at different ecology environment in Taihu LakeScientific Reports, 2018
- HS071, A New Furan-type Cytotoxic Metabolite from Streptomyces sp. HS-HY-071The Journal of Antibiotics, 2008
- Bacterial community composition of a shallow hypertrophic freshwater lake in China, revealed by 16S rRNA gene sequencesFEMS Microbiology Ecology, 2007